Home › Chronic-Phase Myeloid Leukemia › New York › New York City
Chronic-Phase Myeloid Leukemia clinical trials in New York City, NY
3 studies for Chronic-Phase Myeloid Leukemia are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
RecruitingPhase 1
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
RecruitingPhase 1/2
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
Chronic-Phase Myeloid Leukemia trials in other cities
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.